Tejnaksh Healthcare Limited (BOM:539428)

Tejnaksh Healthcare Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	114.49	128.97	121.75	117.27	126.76	119.6
Other Revenue	1.24	1.24	0.81	1.42	0.64	-
Revenue	115.73	130.21	122.56	118.69	127.4	119.6
Revenue Growth (YoY)	-8.77%	6.24%	3.26%	-6.84%	6.52%	-31.11%
Cost of Revenue	34.31	35.87	29.46	31.25	30.4	24.4
Gross Profit	81.42	94.34	93.1	87.44	97	95.2
Selling, General & Admin	0.22	0.22	0.58	0.34	0.21	0.12
Other Operating Expenses	52.23	52.13	55.49	48.81	48.17	57.9
Operating Expenses	64.89	61.45	65.12	57.89	55.03	64.83
Operating Income	16.54	32.89	27.98	29.55	41.97	30.37
Interest Expense	-1.35	-3.76	-6.41	-6.08	-4.02	-4.86
Interest & Investment Income	1.5	1.5	2.05	1.33	0.62	0.56
Currency Exchange Gain (Loss)	-0.02	-0.02	-0.04	0.01	-	-
Other Non Operating Income (Expenses)	0.55	1.31	0.17	0.31	-0.52	0.66
EBT Excluding Unusual Items	17.22	31.91	23.75	25.13	38.06	26.74
Gain (Loss) on Sale of Assets	-	-	-	-	-0.45	-0.06
Pretax Income	17.22	31.91	23.75	25.13	37.61	26.68
Income Tax Expense	4.66	9.61	6.11	7.21	9.5	5.99
Earnings From Continuing Operations	12.56	22.31	17.64	17.91	28.11	20.69
Minority Interest in Earnings	1.2	0.97	0.12	-1.09	-0.88	-0.16
Net Income	13.76	23.28	17.76	16.83	27.24	20.53
Net Income to Common	13.76	23.28	17.76	16.83	27.24	20.53
Net Income Growth	-39.57%	31.07%	5.54%	-38.22%	32.67%	-1.78%
Shares Outstanding (Basic)	21	20	20	20	20	20
Shares Outstanding (Diluted)	21	20	20	20	20	20
Shares Change (YoY)	13.09%	-	-	-	-	0.00%
EPS (Basic)	0.65	1.15	0.87	0.83	1.34	1.01
EPS (Diluted)	0.65	1.15	0.87	0.83	1.34	1.01
EPS Growth	-46.56%	31.07%	5.54%	-38.22%	32.67%	-1.78%
Free Cash Flow	-	1.35	33.03	12.96	1.31	7.39
Free Cash Flow Per Share	-	0.07	1.63	0.64	0.06	0.36
Gross Margin	70.36%	72.46%	75.96%	73.67%	76.14%	79.60%
Operating Margin	14.29%	25.26%	22.83%	24.90%	32.94%	25.40%
Profit Margin	11.89%	17.88%	14.49%	14.18%	21.38%	17.16%
Free Cash Flow Margin	-	1.04%	26.95%	10.92%	1.03%	6.18%
EBITDA	25.55	41.84	36.84	38.07	48.27	37.13
EBITDA Margin	22.08%	32.13%	30.06%	32.07%	37.88%	31.04%
D&A For EBITDA	9.02	8.95	8.86	8.51	6.3	6.75
EBIT	16.54	32.89	27.98	29.55	41.97	30.37
EBIT Margin	14.29%	25.26%	22.83%	24.90%	32.94%	25.40%
Effective Tax Rate	27.07%	30.11%	25.73%	28.70%	25.25%	22.44%
Revenue as Reported	117.78	133.01	124.82	120.34	128.23	120.99
Advertising Expenses	-	0.2	0.57	0.26	0.12	0.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.